Home > Press > ISE-CCM Nanotechnology Index is up 2.50% Year to Date
Abstract:
The ISE-CCM Nanotechnology Index (ISE: TNY) is up 2.50% year to date, versus 5.36% for the S&P 500, 7.25% for the DJIA, and 6.01% for the Nasdaq.
TNY was co-developed by Cronus Capital Markets and the International Securities Exchange (ISE) in New York. TNY comprises 17 of
the leading Nanotechnology companies such as; Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY (NASDAQ: FEIC). TNY is currently trading options in the ISE.
Cronus Capital Markets CEO Michael Soni remarked that 'monthly index reports are an important feature of CCM's Index Support Program, especially for an index like TNY which covers an important aspect of the capital markets and receives significant investor interest.-
CCM Index Reports, available at no cost to investors and the media, include index descriptions, objectives, volatility analysis, performance returns, product specifications, component breakdowns and component profiles with news links. The TNY report is available on www.ccmopportunitybase.com.
####
About Cronus Capital Markets
Cronus Capital Markets® (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. Our equity indexes receive international attention and represent important new benchmarks of growth.
For more information, please click here
Contacts:
GroupWeb EmailWire.Com
Web: http://www.emailwire.com
Phone: 281-645-4086
Copyright © GroupWeb EmailWire.Com
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||